EDAITUTOR
ED Reference · Anaphylaxis v0.1 · adult & paeds Educational use only

Anaphylaxis

A clinical diagnosis — IM adrenaline first, adrenaline early. One brief, two populations: switch between adult and paediatric dosing and pathways.

Adrenaline IMAnterolateral thighRepeat q5min
Population

🔴 Adrenaline first. Adrenaline early. Delay = death.

Give IM adrenaline into the anterolateral thigh the moment anaphylaxis is recognised — do not wait for IV access, hypotension, a rash, antihistamines, steroids or investigations. There is no absolute contraindication to IM adrenaline in life-threatening anaphylaxis (not age, hypertension, cardiac disease or pregnancy). Lay the patient flat; sudden standing or sitting can be fatal. Repeat every 5 minutes if compromise persists.

Full interactive decision pathway

Step-through adultpaediatric anaphylaxis on ED AI Tutor Clinical Pathways — recognition → adrenaline → ABCDE → refractory → disposition.

Open pathway
Recognise
  • A clinical diagnosis — a serious, rapid-onset (minutes–hours) systemic hypersensitivity reaction
  • Suspect after likely allergen exposure with airway, breathing or circulation compromise
  • Or two-or-more systems involved: skin/mucosa, respiratory, cardiovascular, severe/persistent GI
  • Isolated hypotension after a known allergen can be diagnostic — SBP <90 or >30% fall
  • In children, respiratory features predominate and may resolve before arrival
🔴 ruleSkin signs are absent in 10–20% — their absence never excludes anaphylaxis. Keep it in the differential for unexplained distributive shock.
🟢 ANZCOR · WAO · RCHEM Cases
Systems
  • Skin / mucosa — urticaria, flushing, angioedema, lip/tongue/face swelling
  • Respiratory — wheeze, stridor, hoarse voice, throat tightness, cough, hypoxaemia
  • Cardiovascular — hypotension, tachycardia, pallor, syncope, collapse, arrest
  • Gastrointestinal — severe crampy pain, repetitive vomiting (severe/persistent GI = a sign of any-cause anaphylaxis)
⚪ tipTongue (not lip) swelling, drooling, hoarse voice or stridor signal upper-airway involvement — prepare for a difficult airway early.
🟢 ANZCOR · RCHLITFL
Position
  • Lay flat (or sit with legs extended) — do NOT stand or walk
  • Keep flat for at least 1 hour after symptoms resolve
  • Lateral position if vomiting or unconscious
  • Left-lateral tilt if pregnant; semi-recumbent (never abruptly upright) if severe respiratory distress
  • Pale, floppy infant → treat as circulatory compromise
🔴 fatalSudden standing, sitting up or walking during anaphylaxis can precipitate cardiac arrest ("empty ventricle").
🟢 ANZCOR · ASCIA
Act now
  • Call for help · move to a resus-capable area · remove the trigger if feasible
  • IM adrenaline immediately — anterolateral thigh
  • High-flow oxygen · continuous monitoring (SpO₂, ECG, BP)
  • IV/IO access — but never delay adrenaline to get it
🟢 doseAdult: adrenaline 0.5 mg IM (0.5 mL of 1 mg/mL), repeat q5min.Paeds: 0.01 mg/kg IM of 1:1000 (max 0.5 mg), repeat q5min — see calculator below.
🟢 ANZCOR · RCHEM Cases
IM Adrenaline — first-line, life-saving Adult dosingPaediatric dosing
Adult IM dose · 1 mg/mL (1:1000) 0.5 mg = 0.5 mL IM, mid-anterolateral thigh

Repeat every 5 minutes while airway, breathing or circulatory compromise persists. Adults ≥50 kg receive the full 0.5 mg. The thigh beats deltoid or subcutaneous — faster, more reliable absorption.

Safety No absolute
contraindication

Do not reduce or withhold for age, hypertension or coronary disease. IV adrenaline boluses are NOT routine initial treatment — far greater medication-error and arrhythmia risk. Do not use subcutaneous adrenaline.

⚪ pitfallUnder-dosing kills. A single 0.3 mg auto-injector may deliver only a fraction of the weight-based dose in a heavy adult — draw up the full 0.5 mg from the ampoule with a 1 mL syringe.
Paediatric IM dose · 1:1000 0.01 mg/kg = 0.01 mL/kg · max 0.5 mg (0.5 mL)

Anterolateral thigh, repeat every 5 minutes if symptoms persist. In a child with anaphylaxis and known asthma, always give adrenaline first, then asthma medications.

Measurement safety Beware
< 0.1 mL

Volumes under 0.1 mL are hard to measure and prone to 10× overdose under stress. Use a 1 mL syringe. Do not use subcutaneous adrenaline (unreliable absorption).

Paediatric adrenaline & fluid calculator

Enter actual weight. Deterministic — 0.01 mL/kg of 1:1000 (max 0.5 mL) and 20 mL/kg crystalloid. Always cross-check against the RCH chart below and local guidelines.

kg

Infusion recipe (RCH, non-tertiary): 1 mL of 1:1000 adrenaline in 1000 mL sodium chloride 0.9% ≈ 1 µg/mL; start 5 mL/kg/hr; dedicated line, pump, anti-reflux valve; titrate; avoid high rates >2 hr; continuous vitals, 12-lead ECG and conscious-state monitoring. Follow local infusion guidelines and senior/retrieval advice.

Age (yrs)Weight (kg)Adrenaline 1:1000 (mL)Auto-injector device
<1<7.50.1 *Not available
1–2100.1EpiPen Jr 150 µg
(7.5–20 kg, <5 yrs)
2–4150.15
4–5200.2
5–10300.3EpiPen 300 µg
(>20 kg, ≥5 yrs)
10–12400.4
>12>500.5Anapen 500 µg
(>50 kg, >12 yrs)
🔴 note* Volumes <0.1 mL are difficult to measure accurately and prone to 10× overdose — RCH gives a minimum of 0.1 mL in the smallest infants.
🟢 RCH Anaphylaxis CPG · ANZCOR · ASCIA🟢 ANZCOR · ASCIA · EM Cases · LITFL
ABCDE — after adrenaline AdultPaediatric
A

Airway

  • Voice change, stridor, tongue/floor-of-mouth swelling, drooling
  • High-flow O₂ · call an experienced airway clinician early
  • Prepare for a difficult airway; consider early controlled intubation if swelling progresses
  • Nebulised adrenaline may temporise upper-airway oedema — never replaces IM
CICO → FONA ready
B

Breathing

  • Oxygen for hypoxaemia; monitor RR and SpO₂
  • Salbutamol for persistent bronchospasm after adrenaline
  • Bronchodilators do not treat oedema, vasodilatation, capillary leak or shock
  • Persistent systemic features → keep repeating IM adrenaline
Adrenaline > salbutamol
C

Circulation

  • Cardiac monitoring · frequent BP · large-bore IV or IO
  • Bolus 500–1000 mL warmed crystalloid for hypotension
  • Bolus 20 mL/kg isotonic crystalloid if shocked
  • Reassess and repeat — severe shock may need several boluses
  • Do not delay IM adrenaline to obtain access
SBP <90 = shock20 mL/kg, repeat
D/E

Disability / Exposure

  • Assess conscious state; watch for deterioration
  • Expose to find the trigger (sting, patch, infusion) and stop ongoing exposure
  • Reassess after every adrenaline dose
  • Escalate early if not improving
Reassess q5min
⚪ keyAnaphylaxis causes profound vasodilatation and rapid intravascular volume loss — adrenaline + fluids together. Salbutamol, antihistamines and steroids do not reverse shock.
Refractory anaphylaxis AdultPaediatric
🔴 definitionAnaphylaxis needing ongoing treatment for persisting respiratory or cardiovascular compromise despite 2 appropriately-dosed, correctly-given IM adrenaline doses, correct positioning, oxygen and adequate fluids.

IV adrenaline infusion

Monitored resus only

Escalate to a titratable IV adrenaline infusion per local critical-care protocol after 2 IM doses fail. Infusion pump, labelled standard concentration, continuous ECG/BP/SpO₂; consider arterial line in profound shock.

Peripheral infusion (RCH, non-tertiary): 1 mL 1:1000 in 1000 mL saline (≈1 µg/mL), start 5 mL/kg/hr (≈0.1 µg/kg/min); dedicated line, pump, anti-reflux valve; titrate; avoid high rates >2 hr.

Experienced clinicians

Avoid IV boluses

Peri-arrest only

Routine IV boluses cause hypertension, dysrhythmia and ischaemia. Small boluses only by experienced resuscitationists as a peri-arrest bridge.

IV bolus not recommended; in peri-arrest, adrenaline 1 µg/kg IV per resuscitation resources.

High error risk

Persistent vasoplegia

Add support

Continue reassessed crystalloid. Add a second vasopressor if shock persists despite adequate adrenaline infusion. Seek ICU early; bedside ultrasound for ventricular function and competing shock causes.

ICU / retrieval

On a beta-blocker?

Glucagon

Persistent hypotension/bradycardia despite adrenaline → consider IV glucagon under senior critical-care guidance. Anticipate vomiting/aspiration and hyperglycaemia.

Senior-led

Reassess the diagnosis

Not improving?

Check dose/site, ongoing exposure — then tension pneumothorax, severe asthma, PE, sepsis, cardiogenic shock, haemorrhage, isolated angioedema.

Wrong dose/site?

Chest pain — Kounis

Allergic ACS

Mediator-driven coronary vasospasm, plaque rupture or stent thrombosis. Treat the anaphylaxis and the ACS together; correctly-dosed IM adrenaline stays indicated when severe.

Treat both

Escalate & retrieve

>2 doses / infusion

Seek expert critical-care / paediatric transport advice for >2 doses or an infusion. Consider transfer for care beyond local capability — PIPER for paediatric retrieval in Victoria.

PIPER · confirm locally

Reassess the diagnosis

Not improving?

Check adrenaline dose and injection site, ongoing allergen exposure, and consider severe asthma or an alternative cause of shock.

Wrong dose/site?

AMAX4 — the crashing patient Hard deck · 4 minutes

For the unconscious or peri-arrest anaphylaxis/asthma patient (adult or child), time to hypoxic brain injury is about 4 minutes. Most young people with anaphylaxis die from bronchospasm. Prioritise first-pass oxygenation: RSI to a cuffed ETT — supraglottic devices and bag-valve-mask cannot overcome the very high airway pressures (50–100 cmH₂O) of severe bronchospasm. Use a paralytic, video laryngoscopy and the best intubator in the room; declare can't-intubate-can't-oxygenate early and be ready for surgical front-of-neck access. Keep giving IM/IV adrenaline throughout.

⚪ AMAX4 algorithm — Dr Ben McKenzie · amax4.com/algorithm · see also LITFL & EM Cases Ep 187
Adjuncts — not first-line
  • Antihistamines — may ease itch, urticaria, flushing; do not treat airway oedema, bronchospasm or shock
  • Corticosteroids — delayed onset; do not reverse acute compromise; no proven prevention of biphasic reactions
  • Neither must ever delay adrenaline
  • Give antihistamines only after adrenaline and resuscitation, once stable — non-sedating oral preferred
  • Reserve steroids for a separate indication (e.g. persistent asthma / protracted bronchospasm)
⚪ evidenceNo demonstrated mortality benefit from H1/H2 antihistamines or steroids. RCH: antihistamines, corticosteroids and leukotriene antagonists should not be given in acute anaphylaxis.
🟢 ANZCOR · RCHEM Cases · LITFL
Investigations
  • Clinical diagnosis — investigations must never delay treatment
  • Guided by severity: ECG, VBG/ABG, lactate, electrolytes/renal, glucose
  • Troponin if chest pain, ECG changes or significant cardiac disease (think Kounis)
  • Usually none required in children
  • Serum tryptase only where the diagnosis is genuinely uncertain / atypical, per local timing
⚪ tryptaseA normal tryptase does not exclude anaphylaxis (often normal in food-triggered reactions). If sent: baseline after resuscitation begins, ~1–2 h, and ~24 h / at follow-up.RCH: no role in acute management; only in significant diagnostic doubt or with allergy-specialist input.
🟢 RCH · ASCIAEM Cases · LITFL · ASCIA
Observation & disposition AdultPaediatric

Minimum 4 hours

Lower-risk

Shorter observation

All children observed in a setting able to manage deterioration for at least 4 hours after the last adrenaline dose (or after symptom onset if none given).

Shorter monitored observation may suit prompt resolution after one IM dose, normal vitals, no severe asthma, no ongoing absorption, and reliable access to care + autoinjectors.

Prolonged / admit

Higher-risk

>1 (paeds: >2) adrenaline doses, adrenaline infusion or IV fluids; circulatory involvement; delayed adrenaline; severe respiratory compromise or significant hypotension; poorly-controlled asthma; previous biphasic/severe reaction; unknown trigger or ongoing absorption; isolated location; late-evening presentation.

Admit — monitored

Escalate

Persistent/recurrent symptoms, anaphylactic shock, airway intervention, adrenaline infusion, significant ischaemia/dysrhythmia, major comorbidity, or ongoing oxygen/bronchodilator/vasopressor need. Overnight admission per RCH criteria.

⚪ biphasicBiphasic reactions are uncommon but can follow apparent resolution; greater initial severity and delayed or repeated adrenaline increase the risk. Cardiorespiratory arrest >4 hours after exposure is rare.
Before discharge — every patient leaves equipped

Adrenaline autoinjector

If indicated

Prescribe/supply — commonly two devices. Check correct strength, demonstrate with a trainer, and have the patient/parent demonstrate back.

By weight: 150 µg 7.5–20 kg · 300 µg >20 kg · 500 µg >50 kg. PBS-available for children with a history of anaphylaxis. Drug-only anaphylaxis is generally not prescribed a device.

Adults: 300 µg or 500 µg per weight/availability. Prefer the strength closest to the weight-based dose.

Written action plan

ASCIA plan

Individualised ASCIA Action Plan for Anaphylaxis. Adrenaline immediately for recurrence, call an ambulance after use, and do not stand or walk suddenly afterwards.

Trigger & education

Avoidance

Document the suspected trigger; give avoidance advice and label-reading where relevant. Avoid broad, unverified allergy labels. Inform school/daycare and carers. Consider a MedicAlert.

Follow-up

Referral

GP follow-up and referral to allergy/immunology (paediatrician for children). Optimise asthma control and review cardiovascular medications where relevant.

⚪ resourceAllergy & Anaphylaxis Australia and ASCIA provide patient education, action plans and trainer resources. Severity of previous reactions does not predict future risk — safe discharge planning is essential.
Red flags — act / escalate now
  • Airway swellingTongue/throat swelling, stridor, hoarse voice, drooling → adrenaline now, early airway expert, prepare for CICO.
  • Isolated shockHypotension or collapse after a likely allergen with no rash — still anaphylaxis until proven otherwise.
  • 2 doses, no betterRefractory anaphylaxis → IV adrenaline infusion, fluids, ICU/retrieval.
  • Crashing patientUnconscious or peri-arrest from bronchospasm → AMAX4: RSI to a cuffed ETT, 4-minute hard deck.
  • Sudden posture changeStanding, sitting up or walking during anaphylaxis can cause arrest — keep flat.
  • Chest painConsider Kounis syndrome — treat anaphylaxis and ACS together.
  • Known asthmaAdrenaline first, then asthma treatment — asthma raises fatality risk.
🟢 ANZCOR · RCH · ASCIA · EM Cases · LITFL · AMAX4

ED AI Tutor — ED Reference Series · v0.1 · For clinician education only. Not a substitute for clinical judgement, local guidelines or senior oversight. Adult and paediatric doses shown are guideline reference values — verify every dose before administration.